WASHINGTON, D.C. – Today, Congresswoman Doris Matsui (D-CA), a senior member of the House Energy and Commerce Committee, applauded the passage of the bipartisan H.R. 133, which provides funding for fiscal year 2021. The funding package includes Matsui-backed legislation and significant Democratic priorities.
“Today, we passed a government spending bill that looks towards the future and makes critical investments to support our nation’s health care system, combat climate change, and help the country begin to recover from the COVID-19 pandemic,” said Congresswoman Matsui. “This package includes vital funding and policies that I worked hard to include that support several of our nation’s most pressing health care needs. I am proud to have led several efforts that will become law with the passage of this package, including my bills to invest in Medicare beneficiary access to care at home, to provide for the permanent expansion of Medicare telemental health benefits, and to protect public health by requiring the modernization of outdated drug labels. I am also particularly encouraged that $600 million in funding will be dedicated to growing our Certified Community Behavioral Health Centers program, which I have long championed to expand Americans’ access to addiction and mental health treatment in community-based settings.”
“I realize that climate change will continue to be the defining fight of our lives, and we are experiencing its consequences right now,” Matsui continued. “That’s why I fought for robust funding for climate initiatives including a $100 million renewal of diesel emissions reduction funding. We also live in one of the most flood-prone regions in the country, and that’s why I fought hard to secure full funding for programs and projects that will continue to keep our community safe. This bill is critical to provide the certainty of full-year government funding, and I look forward to building upon these important provisions in the future.”
Matsui priorities included in the spending package for FY2021:
- Several bills introduced by Rep. Matsui, including:
- Continuing Access to In-Home IVIG Act (H.R.7839) that extends and expands access to Intravenous Immunoglobulin (IVIG) treatment administered in the home for Medicare patients with primary immunodeficiency diseases (PIDD).
- MODERN Labeling Act (H.R. 5668) that allows the U.S. Food and Drug Administration (FDA) to require modifications of outdated labeling for generic drugs to reflect new information, such as new indications or safety-related information discovered after post-market use.
- Telemental Health Expansion Act (H.R. 5201) that permanently expands Medicare beneficiaries’ access to high-quality mental health treatment by increasing the availability of behavioral telehealth services.
- Extends funding for the ten-state Certified Community Behavioral Health Clinic (CCBHC) demonstration program through September 30, 2023 and provides $600 million for the CCBHC Expansion Grant program. This extension builds on Rep. Matsui’s landmark 2014 legislation, the Excellence in Mental Health Act, which first established the pilot program for federally-qualified community behavioral health centers.
- $31 million for the C.W. Bill Young Cell Transplantation Program and $18.26 million for the National Cord Blood Inventory. Rep. Matsui Co-Chairs the Congressional Caucus to Cure Blood Cancers and Other Blood Disorders and is the lead sponsor of H.R. 4764, the TRANSPLANT Act, legislation to reauthorize the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory. Rep. Matsui has long been a Congressional champion of federal funding for the vital national bone marrow and cord blood registry and coordinating centers, which facilitate bone marrow and cord blood donations.
- $6 million for the CDC’s Muscular Dystrophy program and $10 million for Duchenne research through the Defense Department’s Congressionally Directed Medical Research Program. Rep. Matsui led the appropriations request for both federal Duchenne Muscular Dystrophy research programs.
- $7.5 million for the Bone Marrow Failure Research Program (BMFRP) through the Defense Department’s Congressionally Directed Medical Research Program. In the past year, the Veterans Administration has established that there is sufficient evidence that service members exposed to contaminants in the water supply at Camp Lejeune later developed bone marrow failure diseases. Given this connection, Rep. Matsui led the initial request and an amendment to increase funding by $4.5 million over FY20, for a total of $7.5 million in FY21, to support additional research projects for the treatment of bone marrow failure.
- Includes Rep. Matsui's Diesel Emission Reduction Act (H.R. 1768) that provides $100 million in grant funding to replace older, dirtier diesel engines with cleaner technologies that improve air quality and reduce emissions.
- Includes a Yolo Bypass study based off Rep. Matsui's Yolo Bypass System Improvement Act (H.R. 6684).
- $13 billion for the Federal Transit Administration to support public transportation which reflects Rep. Matsui's call for strong funding.
- $1.1 billion for the Corporation for National and Community Service (CNCS), an increase of $40 million above the 2020 enacted level in response to calls from Rep. Matsui, a Co-Chair of the National Service Caucus.
- $20 million for a consolidated interim nuclear storage program in response to Rep. Matsui’s call for new funding.
# # #